| Item Type | Name |
|
Academic Article
|
Effect of ex vivo cytokine treatment on human cord blood engraftment in NOD-scid mice.
|
|
Academic Article
|
Murine allogeneic in vivo stem cell homing(,).
|
|
Academic Article
|
Mutations in bone marrow-derived stromal stem cells unmask latent malignancy.
|
|
Academic Article
|
Expression of CD25 independently predicts early treatment failure of acute myeloid leukaemia (AML).
|
|
Academic Article
|
Homing and conversion of murine hematopoietic stem cells to lung.
|
|
Academic Article
|
Rituximab based therapy followed by autologous stem cell transplantation leads to superior outcome and high rates of PCR negativity in patients with indolent B-cell lymphoproliferative disorders.
|
|
Concept
|
Hematopoietic Stem Cell Transplantation
|
|
Concept
|
Mesenchymal Stem Cell Transplantation
|
|
Concept
|
Peripheral Blood Stem Cell Transplantation
|
|
Concept
|
Stem Cell Transplantation
|
|
Academic Article
|
Early relapse of Burkitt lymphoma heralded by a bone marrow necrosis and numb chin syndrome successfully treated with allogeneic stem cell transplantation.
|
|
Academic Article
|
Automated red blood cell exchange for acute drug removal in a patient with sirolimus toxicity.
|
|
Academic Article
|
Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies.
|
|
Academic Article
|
Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma.
|
|
Academic Article
|
Automated red blood cell exchange in preparation for filgrastim mobilization of autologous peripheral blood hematopoietic progenitor cells in a patient with sickle cell anemia.
|
|
Academic Article
|
Country-Level Macroeconomic Indicators Predict Early Post-Allogeneic Hematopoietic Cell Transplantation Survival in Acute Lymphoblastic Leukemia: A CIBMTR Analysis.
|
|
Academic Article
|
Calcineurin inhibitor-free GVHD prophylaxis with sirolimus and mycophenolate mofetil combination.
|
|
Academic Article
|
Hematopoietic Cell Transplant (HCT) in the Elderly: Myths, Controversies and Unknowns.
|
|
Academic Article
|
Assessment of Impact of HLA Type on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia.
|
|
Academic Article
|
Staging Systems for Newly Diagnosed Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation: The Revised International Staging System Shows the Most Differentiation between Groups.
|
|
Academic Article
|
Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia.
|
|
Academic Article
|
Elderly do benefit from induction chemotherapy: High dose mitoxantrone-based ("5 + 1") induction chemotherapy regimen in newly diagnosed acute myeloid leukemia.
|
|
Academic Article
|
Effect of Conditioning Regimen Dose Reduction in Obese Patients Undergoing Autologous Hematopoietic Cell Transplantation.
|
|
Academic Article
|
Randomized controlled trial of individualized treatment summary and survivorship care plans for hematopoietic cell transplantation survivors.
|
|
Academic Article
|
Bacterial blood stream infections (BSIs), particularly post-engraftment BSIs, are associated with increased mortality after allogeneic hematopoietic cell transplantation.
|
|
Academic Article
|
Association of Antiepileptic Medications with Outcomes after Allogeneic Hematopoietic Cell Transplantation with Busulfan/Cyclophosphamide Conditioning.
|
|
Academic Article
|
Autologous Hematopoietic Stem Cell Transplantation for Male Germ Cell Tumors: Improved Outcomes Over 3 Decades.
|
|
Academic Article
|
Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report.
|
|
Academic Article
|
Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study.
|
|
Academic Article
|
Outcomes of rituximab-BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation.
|
|
Academic Article
|
The Role of Donor Lymphocyte Infusion (DLI) in Post-Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era.
|
|
Academic Article
|
Survival outcomes of allogeneic hematopoietic cell transplants with EBV-positive or EBV-negative post-transplant lymphoproliferative disorder, A CIBMTR study.
|
|
Academic Article
|
Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era.
|
|
Academic Article
|
Impact of type of reduced-intensity conditioning regimen on the outcomes of allogeneic haematopoietic cell transplantation in classical Hodgkin lymphoma.
|
|
Academic Article
|
Facing COVID-19 in the hematopoietic cell transplant setting: A new challenge for transplantation physicians.
|
|
Academic Article
|
COVID-19 pandemic and impact on hematopoietic stem cell transplantation.
|
|
Academic Article
|
Strongyloides stercoralis hyperinfection syndrome in mantle cell lymphoma in post-transplant setting.
|
|
Academic Article
|
Survival following allogeneic transplant in patients with myelofibrosis.
|
|
Academic Article
|
Managing patients with hematological malignancies during COVID-19 pandemic.
|
|
Academic Article
|
The Concentration of Total Nucleated Cells in Harvested Bone Marrow for Transplantation Has Decreased over Time.
|
|
Academic Article
|
Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report.
|
|
Academic Article
|
Mesenchymal Stem Cells in COVID-19: A Journey from Bench to Bedside.
|
|
Academic Article
|
Elotuzumab-based maintenance therapy following autologous stem cell transplant in multiple myeloma deepens post-transplant responses.
|
|
Academic Article
|
A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes.
|
|
Academic Article
|
Comparison of outcomes of HCT in blast phase of BCR-ABL1- MPN with de novo AML and with AML following MDS.
|
|
Academic Article
|
Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myelogenous Leukemia and Myelodysplastic Syndromes with Low/Intermediate but not High Disease Risk Index: A Center for International Blood and Marrow Transplant Research Study.
|
|
Academic Article
|
Novel prognostic scoring system for autologous hematopoietic cell transplantation in multiple myeloma.
|
|
Academic Article
|
Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States.
|
|
Academic Article
|
Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patients.
|
|
Academic Article
|
Challenges of Cellular Therapy During the COVID-19 Pandemic.
|
|
Academic Article
|
Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide.
|
|
Academic Article
|
Post-allogeneic hematopoietic stem cell transplantation viral reactivations and viremias: a focused review on human herpesvirus-6, BK virus and adenovirus.
|
|
Academic Article
|
Targeted and cytotoxic therapies as maintenance treatment for non-transplant eligible patients with acute myeloid leukemia.
|
|
Academic Article
|
Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia.
|
|
Academic Article
|
Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML.
|
|
Academic Article
|
Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors.
|
|
Academic Article
|
Outcomes of Allogeneic Hematopoietic Cell Transplantation in T Cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research.
|
|
Academic Article
|
Number of HLA-Mismatched Eplets Is Not Associated with Major Outcomes in Haploidentical Transplantation with Post-Transplantation Cyclophosphamide: A Center for International Blood and Marrow Transplant Research Study.
|
|
Academic Article
|
The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis.
|
|
Academic Article
|
Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients.
|
|
Academic Article
|
Health-Related Quality of Life Outcomes in Older Hematopoietic Cell Transplantation Survivors.
|
|
Academic Article
|
Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis.
|
|
Academic Article
|
Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation in Multiple Myeloma.
|
|
Academic Article
|
Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis.
|
|
Academic Article
|
Post-transplantation cyclophosphamide is associated with increased bacterial infections.
|